Caption: Hawkins v. Danaher Corp., et al.
Case No.: 23-02055 (AHA)
Jurisdiction: U.S. District Court for the District of Columbia
Judge: Hon. Amir H. Ali
Summary
On August 4, 2025, Judge Amir H. Ali granted in part Danaher Corporation's motion to dismiss a securities class action. He held that plaintiffs didn't adequately plead falsity or scienter for most forward-looking statements under the PSLRA. Some present statements survived, though. The case, based on alleged misleading projections about bioprocessing demand amid COVID shifts, was partially dismissed without prejudice. This leaves room for section 10(b) and 20(a) claims on key points.
Underlying Lawsuit
The suit came from lead plaintiffs Brenda Hawkins and Derek Einersen. They alleged Danaher and executives Rainer Blair, Matthew McGrew, and Emmanuel Ligner violated sections 10(b) and 20(a) of the Exchange Act. Claims focused on statements from January 2022 to October 2023. These involved optimistic forecasts despite known declines in COVID demand, inventory buildup, and biotech funding woes, The complaint used internal forecasts and confidential witnesses to claim misleading omissions. 
Defendants’ Motion
Defendants pushed back hard. They said many statements were forward-looking and protected by the PSLRA safe harbor. No actual knowledge of falsity was pled, they argued. For present statements, defendants claimed puffery or lack of materiality. They also hit scienter and loss causation as weak under PSLRA standards.
Plaintiffs’ Opposition
Plaintiffs opposed defendants’ arguments. They argued statements misled investors by omitting inventory issues and funding crunches. These caused stock drops when truths emerged, they said. Plaintiffs claimed scienter from executives' access to contrary data. They insisted no safe harbor applied due to inadequate cautions.
Court’s Ruling
The Court granted dismissal in part. Judge Ali found most forward-looking statements protected by the safe harbor. He let certain present statements proceed. One set of April 2022 projections also survived. The Court rejected section 20(a) dismissal since primary claims partially stood.
Court’s Rationale
Falsity. Some present statements weren't false. The Court saw them as puffery, like "exceptional portfolio." No objective verification possible. But others, on demand and inventory, could be misleading. Plaintiffs pled omissions of key facts, like declining COVID sales.
Materiality. Judge Ali held revenue projections material. Reasonable investors would care about them. But puffery statements were too vague. No substantial likelihood of importance. For surviving claims, context made them actionable. The April 2022 ones lacked meaningful cautions.
Scienter and Loss Causation. The Court skipped deep dives here for dismissed statements and claims. But for surviving claims, strong inference of scienter existed because of defendants extreme recklessness from omitted data. Plaintiffs met PSLRA's particularity burden with witness accounts.
Final Disposition
Claims under sections 10(b), 20(a), and Rule 10b-5 were dismissed in part without prejudice. The Court directed proceedings on remaining issues.
